Key facts
- This page summarizes Halley E. Gilbert's Form 4 filing for Vaxcyte, Inc. (PCVX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 Jun 2024, 16:10.
Halley E. Gilbert - 06 Jun 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)
- Form type
- 4
- Accepted by SEC
- 10 Jun 2024, 16:10:47 UTC
- Previous filing
- 05 Jun 2024
- Next filing
- 18 Jun 2024
- SEC filing
- View on sec.gov
- Reporting owner signature
- Halley E. Gilbert, by /s/ Peter N. Efremenko, Attorney-In-Fact
Source evidence
5 source fields
Reporting owner
1 detail
Key filing fact
Halley E. Gilbert filed Form 4 for Vaxcyte, Inc. (PCVX) on 10 Jun 2024.
Change
- Previous filing in this sequence was filed on 05 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCVX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,550
- Change %
- +28%
- Price
- $0.000000
- Shares after
- 7,175
- Date
- 06 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PCVX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +7,250
- Change %
- Price
- $0.000000
- Shares after
- 7,250
- Date
- 06 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,250
- Exercise price
- $72.51
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
Footnote F2
The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.